1 / 27

Tuberculosis in the United States National Tuberculosis Surveillance System Highlights from 2010

Tuberculosis in the United States National Tuberculosis Surveillance System Highlights from 2010. National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Division of Tuberculosis Elimination. Reported TB Cases United States, 1982–2010*. No. of Cases. Year.

marvel
Download Presentation

Tuberculosis in the United States National Tuberculosis Surveillance System Highlights from 2010

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Tuberculosis in the United StatesNational Tuberculosis Surveillance SystemHighlights from 2010 National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of Tuberculosis Elimination

  2. Reported TB Cases United States, 1982–2010* No. of Cases Year *Updated as of July 21, 2011

  3. TB MorbidityUnited States, 2005–2010 *Cases per 100,000. Updated as of July 21, 2011

  4. TB Case Rates,* United States, 2010 D.C. <3.6 (2010 national average) >3.6 *Cases per 100,000.

  5. TB Case Rates* by Age Group United States, 1993–2010 Cases per 100,000 Age Group (years) * Updated as of July 21, 2011

  6. Reported TB Cases by Age Group, United States, 2010

  7. TB Case Rates by Age Group and Sex, United States, 2010 Cases per 100,000

  8. TB Case Rates by Race/Ethnicity* United States, 2003–2010** Cases per 100,000 *All races are non-Hispanic. **Updated as of July 21, 2011.

  9. TB Case Rates by Age Group and Race/Ethnicity* United States, 2010 Cases per 100,000 *All races are non-Hispanic. Persons reporting two or more races accounted for less than 1% of all cases.

  10. Reported TB Cases by Race/Ethnicity*United States, 2010 *All races are non-Hispanic. Persons reporting two or more races accounted for less than 1% of all cases.

  11. Number of TB Cases inU.S.-born vs. Foreign-born Persons United States, 1993–2010* No. of Cases *Updated as of July 21, 2011

  12. Trends in TB Cases in Foreign-born PersonsUnited States, 1990 – 2010* No. of Cases Percentage *Updated as of July 21, 2011

  13. Reported TB Cases by Origin and Race/Ethnicity,* United States, 2010 Foreign-born** U.S.-born *All races are non-Hispanic. Persons reporting two or more races accounted for less than 1% of all cases. ** American Indian or Alaska Native and Native Hawaiian or Other Pacific Islander accounted for less than 1% of foreign-born cases and are not shown.

  14. Percentage of TB Cases Among Foreign-born Persons, United States* 2000 2010 DC DC >50% 25%–49% *Updated as of July 21, 2011 <25%

  15. TB Case Rates in U.S.-born vs. Foreign-born Persons, United States, 1993 – 2010* Cases per 100,000 *Updated as of July 21, 2011

  16. TB Case Rates in U.S.-born vs. Foreign-born Persons, United States*, 1993 – 2010** Cases per 100,000 *Includes the same data as slide 15, but rates presented on a logarithmic scale. **Updated as of July 21, 2011

  17. Countries of Birth of Foreign-born Persons Reported with TB, United States, 2010

  18. Percent of Foreign-born with TB by Time of Residence in U.S. Prior to Diagnosis, 2010 *Foreign-born TB patients for whom information on length of residence in the U.S. prior to diagnosis is unknown or missing

  19. Primary Anti-TB Drug ResistanceUnited States, 1993 – 2010* % Resistant *Updated as of July 21, 2011 Note: Based on initial isolates from persons with no prior history of TB. Multidrug resistant TB (MDR TB) is defined as resistance to at least isoniazid and rifampin

  20. Primary MDR TBUnited States, 1993 – 2010* No. of Cases Percentage *Updated as of July 21, 2011 Note: Based on initial isolates from persons with no prior history of TB. MDR TB defined as resistance to at least isoniazid and rifampin.

  21. Primary Isoniazid Resistance in U.S.-born vs. Foreign-born PersonsUnited States, 1993 – 2010* % Resistant *Updated as of July 21, 2011 Note: Based on initial isolates from persons with no prior history of TB.

  22. Primary MDR TB in U.S.-born vs. Foreign-born PersonsUnited States, 1993 – 2010* % Resistant *Updated as of July 21, 2011 Note: Based on initial isolates from persons with no prior history of TB. MDR TB defined as resistance to at least isoniazid and rifampin.

  23. XDR TB Case Count Defined on Initial DST*by Year, 1993 – 2010** Case Count Year of Diagnosis * Drug susceptibility test ** Updated as of July 21, 2011 Note: Extensively drug-resistant TB (XDR TB) is defined as resistance to isoniazid and rifampin, plus resistance to any fluoroquinolone and at least one of three injectable second-line anti-TB drugs

  24. Reporting of HIV Test Results in Persons with TB by Age GroupUnited States, 1993 – 2010* % with Test Results *Updated as of July 21, 2011 Note: Includes TB patients with positive, negative, or indeterminate HIV test results. HIV test results not reported from California after 2004. HIV test results not reported from Rhode Island for years 1993-1997. HIV test results not reported from Vermont after 2007.

  25. Estimated HIV Coinfection in Persons Reported with TB, United States, 1993 – 2010* % Coinfection *Updated as of July 21, 2011 Note: Minimum estimates based on reported HIV-positive status among all TB cases in the age group

  26. Mode of Treatment Administration in Persons Reported with TBUnited States, 1993 – 2008* Percentage** *Updated as of July 21, 2011. Data available through 2008 only. **Percentage of total cases in persons alive at diagnosis, with an initial regimen of one or more drugs prescribed, and excluding cases with unknown mode of treatment administration. Directly observed therapy (DOT); Self-administered therapy (SA)

  27. Completion of TB TherapyUnited States, 1993 – 2008* Percentage * Updated as of July 21, 2011. Data available through 2008 only. Note: Includes persons alive at diagnosis, with initial drug regimen of one or more drugs prescribed, who did not die during therapy. Excludes persons with initial isolate rifampin resistant, or patient with meningeal disease, or pediatric patient (aged <15) with miliary disease or positive blood culture.

More Related